JP6367545B2 - ルキソリチニブの重水素化誘導体 - Google Patents
ルキソリチニブの重水素化誘導体 Download PDFInfo
- Publication number
- JP6367545B2 JP6367545B2 JP2013259713A JP2013259713A JP6367545B2 JP 6367545 B2 JP6367545 B2 JP 6367545B2 JP 2013259713 A JP2013259713 A JP 2013259713A JP 2013259713 A JP2013259713 A JP 2013259713A JP 6367545 B2 JP6367545 B2 JP 6367545B2
- Authority
- JP
- Japan
- Prior art keywords
- deuterium
- hydrogen
- compound
- compounds
- pharmaceutically acceptable
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 0 CC1(*)C(*)([C@@](*)(C(*)(*)C#N)[n]2nc(*)c(-c3nc(*)nc4c3c(*)c(*)[n]4)c2*)C(*)(*)C(*)(*)C1(*)* Chemical compound CC1(*)C(*)([C@@](*)(C(*)(*)C#N)[n]2nc(*)c(-c3nc(*)nc4c3c(*)c(*)[n]4)c2*)C(*)(*)C(*)(*)C1(*)* 0.000 description 1
Images
Landscapes
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2013259713A JP6367545B2 (ja) | 2013-12-17 | 2013-12-17 | ルキソリチニブの重水素化誘導体 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2013259713A JP6367545B2 (ja) | 2013-12-17 | 2013-12-17 | ルキソリチニブの重水素化誘導体 |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2018128417A Division JP6830460B2 (ja) | 2018-07-05 | 2018-07-05 | ルキソリチニブの重水素化誘導体 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2015117185A JP2015117185A (ja) | 2015-06-25 |
| JP2015117185A5 JP2015117185A5 (enExample) | 2017-02-09 |
| JP6367545B2 true JP6367545B2 (ja) | 2018-08-01 |
Family
ID=53530252
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2013259713A Active JP6367545B2 (ja) | 2013-12-17 | 2013-12-17 | ルキソリチニブの重水素化誘導体 |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JP6367545B2 (enExample) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2018172421A (ja) * | 2018-07-05 | 2018-11-08 | コンサート ファーマシューティカルズ インコーポレイテッド | ルキソリチニブの重水素化誘導体 |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA3294570A1 (en) * | 2015-06-30 | 2026-03-02 | Eiger Group International, Inc. | Use of r-chloroquine or metabolites, r-rhydroxychloroquine or metabolites, or deuterated analogs of r-chloroquine or rhydroxychloroquine, in treatment of liver inflammation |
| CA3000547C (en) * | 2015-09-29 | 2021-03-23 | Kangpu Biopharmaceuticals, Ltd. | Pharmaceutical composition comprising benzoheterocyclic compound and androgen receptor pathway modulator for prevention or treatment of prostate cancer |
| US10561659B2 (en) * | 2016-05-04 | 2020-02-18 | Concert Pharmaceuticals, Inc. | Treatment of hair loss disorders with deuterated JAK inhibitors |
| JP6802899B2 (ja) * | 2016-07-25 | 2020-12-23 | 深▲セン▼市塔吉瑞生物医▲薬▼有限公司Ｓｈｅｎｚｈｅｎ ＴａｒｇｅｔＲｘ，Ｉｎｃ． | 置換ボロン酸化合物、該化合物を含む医薬組成物およびその使用 |
| GB201907871D0 (en) * | 2019-06-03 | 2019-07-17 | Small Pharma Ltd | Therapeutic compositions |
| AU2021206286A1 (en) * | 2020-01-10 | 2024-08-08 | Consynance Therapeutics, Inc. | Therapeutic combinations of drugs and methods of using them |
| WO2021116503A2 (en) * | 2020-06-02 | 2021-06-17 | Small Pharma Ltd | Deuterated compounds |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| HUE028588T2 (hu) * | 2005-12-13 | 2016-12-28 | Incyte Holdings Corp | Heteroaril-szubsztituált pirrolo[2,3-b]piridinek és pirrolo[2,3-b]pirimidinek mint Janus-kináz inhibitorok |
| CA2792508C (en) * | 2010-03-10 | 2018-01-16 | Incyte Corporation | Piperidin-4-yl azetidine derivatives as jak1 inhibitors |
-
2013
- 2013-12-17 JP JP2013259713A patent/JP6367545B2/ja active Active
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2018172421A (ja) * | 2018-07-05 | 2018-11-08 | コンサート ファーマシューティカルズ インコーポレイテッド | ルキソリチニブの重水素化誘導体 |
Also Published As
| Publication number | Publication date |
|---|---|
| JP2015117185A (ja) | 2015-06-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US20250025467A1 (en) | Deuterated derivatives of ruxolitinib | |
| JP2015117185A (ja) | ルキソリチニブの重水素化誘導体 | |
| US8575221B2 (en) | Derivatives of dimethylcurcumin | |
| CN104725380B (zh) | 卢索替尼的氘代衍生物 | |
| KR102433283B1 (ko) | 룩소리티닙의 중수소화된 유도체 | |
| US10357499B2 (en) | Substituted triazolobenzodiazepines | |
| JP6830460B2 (ja) | ルキソリチニブの重水素化誘導体 | |
| WO2012129381A1 (en) | Deuterated preladenant | |
| HK40060909A (en) | Deuterated derivatives of ruxolitinib | |
| HK40060909B (en) | Deuterated derivatives of ruxolitinib | |
| HK40013863A (en) | Deuterated derivatives of ruxolitinib | |
| HK40013863B (en) | Deuterated derivatives of ruxolitinib | |
| BR112014031204B1 (pt) | Derivados deuterados de ruxolitinib e composição farmacêutica compreendendo os mesmos |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20161215 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20161222 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20171023 |
|
| A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20171019 |
|
| A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20180118 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20180423 |
|
| TRDD | Decision of grant or rejection written | ||
| A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20180507 |
|
| A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20180605 |
|
| A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20180705 |
|
| R150 | Certificate of patent or registration of utility model |
Ref document number: 6367545 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| S111 | Request for change of ownership or part of ownership |
Free format text: JAPANESE INTERMEDIATE CODE: R313111 |
|
| R350 | Written notification of registration of transfer |
Free format text: JAPANESE INTERMEDIATE CODE: R350 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |